<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<html>
<head>
	<meta http-equiv="content-type" content="text/html; charset=utf-8"/>
	<title></title>
	<meta name="generator" content="LibreOffice 6.4.1.2 (MacOSX)"/>
	<meta name="author" content="Gregory Pangborn"/>
	<meta name="created" content="2020-04-09T21:23:00"/>
	<meta name="changedby" content="Gregory Pangborn"/>
	<meta name="changed" content="2020-04-14T14:59:00"/>
	<meta name="AppVersion" content="16.0000"/>
	<meta name="DocSecurity" content="0"/>
	<meta name="HyperlinksChanged" content="false"/>
	<meta name="LinksUpToDate" content="false"/>
	<meta name="ScaleCrop" content="false"/>
	<meta name="ShareDoc" content="false"/>
	<style type="text/css">
		@page { size: 8.5in 11in; margin: 1in }
		p { margin-bottom: 0.1in; direction: ltr; line-height: 115%; text-align: left; orphans: 2; widows: 2; background: transparent }
		p.western { font-family: "Century Schoolbook", serif }
		h1 { margin-left: 0.69in; text-indent: -0.69in; margin-bottom: 0.04in; direction: ltr; line-height: 100%; text-align: center; orphans: 2; widows: 2; background: transparent; page-break-after: avoid }
		h1.western { font-family: "Century Schoolbook", serif; font-size: 14pt; font-weight: bold }
		h1.cjk { font-family: ; font-size: 14pt; font-weight: bold }
		h1.ctl { font-family: ; font-size: 16pt }
		h2 { margin-bottom: 0.04in; direction: ltr; line-height: 100%; text-align: center; orphans: 2; widows: 2; background: transparent; page-break-after: avoid }
		h2.western { font-family: "Century Schoolbook", serif; font-size: 14pt; font-weight: bold }
		h2.cjk { font-family: ; font-size: 14pt; font-weight: bold }
		h2.ctl { font-family: ; font-size: 14pt; font-style: italic; font-weight: bold }
		h3 { margin-top: 0.08in; margin-bottom: 0.08in; direction: ltr; line-height: 100%; text-align: left; orphans: 2; widows: 2; background: transparent; page-break-after: avoid }
		h3.western { font-family: "Century Schoolbook", serif; font-size: 12pt; font-weight: bold }
		h3.cjk { font-family: "Times New Roman"; font-size: 12pt; font-weight: bold }
		h3.ctl { font-family: "Times New Roman"; font-size: 10pt }
		h4 { margin-top: 0in; margin-bottom: 0in; direction: ltr; line-height: 100%; text-align: left; orphans: 2; widows: 2; background: transparent }
		h4.western { font-family: "Century Schoolbook", serif; font-size: 12pt; font-weight: bold }
		h4.cjk { font-family: "Times New Roman"; font-size: 12pt; font-weight: bold }
		h4.ctl { font-family: "Times New Roman"; font-size: 10pt }
		a:link { color: #0000ff; text-decoration: underline }
	</style>
</head>
<body lang="en-US" link="#0000ff" vlink="#800000" dir="ltr">
            <a name="TopOfPage"></a>
            <div class="regnavigation">
                
                <p><a href="DFARS234.html#TopOfPage"><img src="/sites/all/themes/acquisition-responsive/images/prev-part.jpg" alt="Previous Page" border="0"></a></p>
                <p><a href="/dfars#TopOfPage" target="_top"><img src="/sites/all/themes/acquisition-responsive/images/toc.jpg" alt="Table Of Contents" border="0"></a></p>
                <p><a href="DFARS236.html#TopOfPage"><img src="/sites/all/themes/acquisition-responsive/images/next-part.jpg" alt="Next Page" border="0"></a></p>
            </div><p class="western" style="margin-bottom: 0.11in; line-height: 108%">
<br/>
<br/>

</p>
<h1 class="western" style="page-break-before: always"><a name="_Toc37754400"></a><a name="_Toc37677490"></a>
PART 235 - <br/>
Research and Development Contracting</h1>
<p class="western" style="margin-bottom: 0.11in; line-height: 108%; page-break-before: always">
<br/>
<br/>
<br/>

</p>
<p class="western" align="center" style="margin-bottom: 0.11in; line-height: 108%">
<font face="Arial, serif"><b>Table of Contents</b></font></p>
<div id="Table of Contents1" dir="ltr"><p style="margin-bottom: 0.07in; line-height: 108%">
	<a href="#_Toc37754400">PART 235 -  Research and Development
	Contracting</a></p>
	<p style="margin-left: 0.31in; margin-bottom: 0.07in; line-height: 108%">
	<a href="#_Toc37754401">235.001  Definitions.</a></p>
	<p style="margin-left: 0.31in; margin-bottom: 0.07in; line-height: 108%">
	<a href="#_Toc37754402">235.006  Contracting methods and contract
	type.</a></p>
	<p style="margin-left: 0.46in; margin-bottom: 0.07in; line-height: 108%">
	<a href="#_Toc37754403">235.006-70  Manufacturing Technology
	Program.</a></p>
	<p style="margin-left: 0.46in; margin-bottom: 0.07in; line-height: 108%">
	<a href="#_Toc37754404"><span style="letter-spacing: -0.3pt">235.006-71
	 Competition.</span></a></p>
	<p style="margin-left: 0.31in; margin-bottom: 0.07in; line-height: 108%">
	<a href="#_Toc37754405">235.008  Evaluation for award.</a></p>
	<p style="margin-left: 0.31in; margin-bottom: 0.07in; line-height: 108%">
	<a href="#_Toc37754406">235.010  Scientific and technical reports.</a></p>
	<p style="margin-left: 0.46in; margin-bottom: 0.07in; line-height: 108%">
	<a href="#_Toc37754407">235.015-70  Special use allowances for
	research facilities acquired by educational institutions.</a></p>
	<p style="margin-left: 0.31in; margin-bottom: 0.07in; line-height: 108%">
	<a href="#_Toc37754408">235.016  Broad agency announcement.</a></p>
	<p style="margin-left: 0.31in; margin-bottom: 0.07in; line-height: 108%">
	<a href="#_Toc37754409">235.017  Federally Funded Research and
	Development Centers.</a></p>
	<p style="margin-left: 0.46in; margin-bottom: 0.07in; line-height: 108%">
	<a href="#_Toc37754410">235.017-1  Sponsoring agreements.</a></p>
	<p style="margin-left: 0.31in; margin-bottom: 0.07in; line-height: 108%">
	<a href="#_Toc37754411">235.070  Indemnification against unusually
	hazardous risks.</a></p>
	<p style="margin-left: 0.46in; margin-bottom: 0.07in; line-height: 108%">
	<a href="#_Toc37754412">235.070-1  Indemnification under research
	and development contracts.</a></p>
	<p style="margin-left: 0.46in; margin-bottom: 0.07in; line-height: 108%">
	<a href="#_Toc37754413">235.070-2  Indemnification under contracts
	involving both research and development and other work.</a></p>
	<p style="margin-left: 0.46in; margin-bottom: 0.07in; line-height: 108%">
	<a href="#_Toc37754414">235.070-3  Contract clauses.</a></p>
	<p style="margin-left: 0.31in; margin-bottom: 0.07in; line-height: 108%">
	<a href="#_Toc37754415">235.071  Export-controlled items.</a></p>
	<p style="margin-left: 0.31in; margin-bottom: 0.07in; line-height: 108%">
	<a href="#_Toc37754416">235.072  Additional contract clauses.</a></p>
	<p style="margin-left: 0.15in; margin-bottom: 0.07in; line-height: 108%">
	<a href="#_Toc37754417"><span style="text-transform: uppercase">SUBPART
	235.70</span></a></p>
</div>
<p class="western" align="center" style="margin-bottom: 0.11in; line-height: 108%">
<br/>
<br/>

</p>
<p class="western" align="center" style="margin-bottom: 0.11in; line-height: 108%">
<i>(Revised November 27, 2019)</i></p>
<h3 class="western"><a name="_Toc37754401"></a><a name="_Toc37677491"></a><a name="_Toc37345924"></a>
<i><br/>
</i>235.001  Definitions.</h3>
<p class="western" style="margin-bottom: 0.11in; line-height: 108%"> Research
and development  means those efforts described by the Research,
Development, Test, and Evaluation (RDT&E) budget activity
definitions found in the DoD Financial Management Regulation (DoD
7000.14-R), Volume 2B, Chapter 5.</p>
<h3 class="western"><a name="_Toc37754402"></a><a name="_Toc37677492"></a><a name="_Toc37345925"></a>
<br/>
235.006  Contracting methods and contract type.</h3>
<p style="margin-bottom: 0in; line-height: 100%"><b><br/>
</b>(b)(i) 
 Consistent with section 829 of the National Defense Authorization
Act for Fiscal Year 2017 (Pub. L. 114-328), the Under Secretary of
Defense for Acquisition and Sustainment (USD(A&S)) has determined
that the use of cost-reimbursement contracts for research and
development in excess of $25 million is approved, if the contracting
officer executes a written determination and findings that—</p>
<p style="margin-left: 1in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(A)  The level of program risk does not permit realistic
pricing; and</p>
<p style="margin-left: 1in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(B)  It is not possible to provide an equitable and sensible
allocation of program risk between the Government and the contractor.
</p>
<p style="margin-left: 0.75in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(ii)  For major defense acquisition programs as defined in 10
U.S.C. 2430—</p>
<p style="margin-left: 1in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(A)  Follow the procedures at <a href="https://www.acq.osd.mil/dpap/dars/dfars/html/current/234_0.htm#234.004">234.004</a>;
and</p>
<p style="margin-left: 1in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(B)  Notify the milestone decision authority of an intent not
to exercise a fixed-price production option on a development contract
for a major weapon system reasonably in advance of the expiration of
the option exercise period.</p>
<p style="margin-left: 0.75in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(iii)  For other than major defense acquisition programs—</p>
<p style="margin-left: 1in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(A)  Do not award a fixed-price type contract for a development
program effort unless—</p>
<p style="margin-left: 0.5in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(<i>1</i>)  The level of program risk permits realistic
pricing;</p>
<p style="margin-left: 0.5in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(<i>2</i>)  The use of a fixed-price type contract permits an
equitable and sensible allocation of program risk between the
Government and the contractor; and</p>
<p style="margin-left: 0.5in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(<i>3</i>)  A written determination that the criteria of
paragraphs (b)(iii)(A)<i>(1)</i> and (<i>2</i>) of this section have
been met is executed—</p>
<p style="margin-left: 0.75in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
<i>(i)</i>  By the USD(A&S) if the contract is over $25
million and is for: research and development for a non-major system;
the development of a major system (as defined in FAR 2.101); or the
development of a subsystem of a major system; or</p>
<p style="margin-left: 0.75in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
<i>(ii)</i>  By the contracting officer for any development not
covered by paragraph (b)(iii)(A)<i>(3)(i)</i> of this section.</p>
<p style="margin-left: 1in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(B)  Obtain USD(A&S) approval of the Government s
prenegotiation position before negotiations begin, and obtain
USD(A&S) approval of the negotiated agreement with the contractor
before the agreement is executed, for any action that is—</p>
<p style="margin-left: 0.5in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(<i>1</i>)  An increase of more than $250 million in the price
or ceiling price of a fixed-price type development contract, or a
fixed-price type contract for the lead ship of a class;</p>
<p style="margin-left: 0.5in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(<i>2</i>)  A reduction in the amount of work under a
fixed-price type development contract or a fixed-price type contract
for the lead ship of a class, when the value of the work d is $100
million or more; or</p>
<p style="margin-left: 0.5in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(<i>3</i>)  A repricing of fixed-price type production options
to a development contract, or a contract for the lead ship of a
class, that increases the price or ceiling price by more than $250
million for equivalent quantities.</p>
<h4 class="western"><a name="_Toc37754403"></a><a name="_Toc37677493"></a>
<br/>
235.006-70  Manufacturing Technology Program.</h4>
<p class="western" style="margin-bottom: 0.11in; line-height: 108%">In
accordance with 10 U.S.C. 2521(d), for acquisitions under the
Manufacturing Technology Program— 
</p>
<p style="margin-bottom: 0in; line-height: 100%"><br/>
(a)  Award all
contracts using competitive procedures; and</p>
<p style="margin-bottom: 0in; line-height: 100%"><br/>
(b)  Include
in all solicitations an evaluation factor that addresses the extent
to which offerors propose to share in the cost of the project (see
FAR 15.304).</p>
<h4 class="western"><a name="_Toc37754404"></a><a name="_Toc37677494"></a>
<br/>
<span style="letter-spacing: -0.3pt">235.006-71  Competition.</span></h4>
<p style="margin-bottom: 0in; line-height: 100%"><span style="letter-spacing: -0.3pt"><br/>
(a)
 Use of a broad agency announcement with peer or scientific review
for the award of science and technology proposals in accordance with
<a href="https://www.acq.osd.mil/dpap/dars/dfars/html/current/235_0.htm#235.016">235.016</a>(a)
fulfills the requirement for full and open competition (see
<a href="https://www.acq.osd.mil/dpap/dars/dfars/html/current/206_1.htm#206.102">206.102</a>(d)(2)).</span></p>
<p style="margin-bottom: 0in; line-height: 100%"><b><br/>
</b>(b) 
See <a href="https://www.acq.osd.mil/dpap/dars/dfars/html/current/234_0.htm#234.005-1"><span style="letter-spacing: -0.3pt">234.005-1</span></a>
for limitations on the use of contract line items or contract options
for the provision of advanced component development or prototypes of
technology developed under a competitively awarded proposal.</p>
<h3 class="western"><a name="_Toc37754405"></a><a name="_Toc37677495"></a><a name="_Toc37345926"></a>
<span style="letter-spacing: -0.3pt"><br/>
</span>235.008  Evaluation
for award.</h3>
<p class="western" style="margin-bottom: 0.11in; line-height: 108%">See
<a href="https://www.acq.osd.mil/dpap/dars/dfars/html/current/209_5.htm#209.570">209.570</a>
for limitations on the award of contracts to contractors acting as
lead system integrators.</p>
<h3 class="western"><a name="_Toc37754406"></a><a name="_Toc37677496"></a><a name="_Toc37345927"></a>
<br/>
235.010  Scientific and technical reports.</h3>
<p style="margin-bottom: 0in; line-height: 100%"><b><br/>
</b>(b) 
For DoD, the Defense Technical Information Center is responsible for
collecting all scientific and technical reports.  For access to these
reports, follow the procedures at <a href="https://www.acq.osd.mil/dpap/dars/pgi/pgi_htm/PGI235_0.htm">PGI
235.010</a>(b).</p>
<h4 class="western"><a name="_Toc37754407"></a><a name="_Toc37677497"></a>
<br/>
235.015-70  Special use allowances for research facilities
acquired by educational institutions.</h4>
<p style="margin-bottom: 0in; line-height: 100%"><b><br/>
</b>(a) 
<i>Definitions.  </i>As used in this subsection—</p>
<p style="margin-left: 0.5in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(1)   Research facility  means—</p>
<p style="margin-left: 0.75in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(i)  Real property, other than land; and</p>
<p style="margin-left: 0.75in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(ii)  Includes structures, alterations, and improvements,
acquired for the purpose of conducting scientific research under
contracts with departments and agencies of the DoD.</p>
<p style="margin-left: 0.5in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(2)   Special use allowance  means a negotiated direct or
indirect allowance—</p>
<p style="margin-left: 0.75in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(i)  For construction or acquisition of buildings, structures,
and real property, other than land; and</p>
<p style="margin-left: 0.75in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(ii)  Where the allowance is computed at an annual rate
exceeding the rate which normally would be allowed under FAR Subpart
31.3.</p>
<p style="margin-bottom: 0in; line-height: 100%"><br/>
(b)  <i>Policy.</i></p>
<p style="margin-left: 0.5in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(1)  Educational institutions are to furnish the facilities
necessary to perform defense contracts.  FAR 31.3 governs how much
the Government will reimburse the institution for the research
programs.  However, in extraordinary situations, the Government may
give special use allowances to an educational institution when the
institution is unable to provide the capital for new laboratories or
expanded facilities needed for defense contracts.</p>
<p style="margin-left: 0.5in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(2)  Decisions to provide a special use allowance must be made
on a case-by-case basis, using the criteria in paragraph (c) of this
subsection.</p>
<p style="margin-bottom: 0in; line-height: 100%"><br/>
(c) 
<i>Authorization for special use allowance.  </i>The head of a
contracting activity may approve special use allowances only when all
of the following conditions are met—</p>
<p style="margin-left: 0.5in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(1)  The research facility is essential to the performance of
DoD contracts;</p>
<p style="margin-left: 0.5in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(2)  Existing facilities, either Government or nongovernment,
cannot meet program requirements practically or effectively;</p>
<p style="margin-left: 0.5in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(3)  The proposed agreement for special use allowances is a
sound business arrangement;</p>
<p style="margin-left: 0.5in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(4)  The Government's furnishing of Government-owned facilities
is undesirable or impractical; and</p>
<p style="margin-left: 0.5in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(5)  The proposed use of the research facility is to conduct
essential Government research which requires the new or expanded
facilities.</p>
<p style="margin-bottom: 0in; line-height: 100%"><br/>
(d) 
<i>Application of the special use allowance.</i></p>
<p style="margin-left: 0.5in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(1)  In negotiating a special use allowance—</p>
<p style="margin-left: 0.75in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(i)  Compare the needs of DoD and of the institution for the
research facility to determine the amount of the special use
allowance;</p>
<p style="margin-left: 0.75in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(ii)  Consider rental costs for similar space in the area where
the research facility is or will be located to establish the annual
special use allowance;</p>
<p style="margin-left: 0.75in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(iii)  Do not include or allow—</p>
<p style="margin-left: 1in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(A)  The costs of land; or</p>
<p style="margin-left: 1in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(B)  Interest charges on capital;</p>
<p style="margin-left: 0.75in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(iv)  Do not include maintenance, utilities, or other
operational costs;</p>
<p style="margin-left: 0.75in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(v)  The period of allowance generally will be—</p>
<p style="margin-left: 1in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(A)  At least ten years; or</p>
<p style="margin-left: 1in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(B)  A shorter period if the total amount to be allowed is less
than the construction or acquisition cost for the research facility;</p>
<p style="margin-left: 0.75in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(vi)  Generally, provide for allocation of the special use
allowance equitably among the Government contracts using the research
facility;</p>
<p style="margin-left: 0.75in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(vii)  Special use allowances apply only in the years in which
the Government has contracts in effect with the institution. 
However, if in any given year there is a reduced level of Government
research effort which results in the special use allowance being
excessive compared to the Government research funding, a separate
special use allowance may be negotiated for that year;</p>
<p style="margin-left: 0.75in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(viii)  Special use allowances may be adjusted for the period
before construction is complete if the facility is partially occupied
and used for Government research during that period.</p>
<p style="margin-left: 0.5in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(2)  A special use allowance may be based on either total or
partial cost of construction or acquisition of the research facility.</p>
<p style="margin-left: 0.75in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(i)  When based on total cost neither the normal use allowance
nor depreciation will apply—</p>
<p style="margin-left: 1in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(A)  During the special use allowance period; and</p>
<p style="margin-left: 1in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(B)  After the educational institution has recovered the total
construction or acquisition cost from the Government or other users.</p>
<p style="margin-left: 0.75in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(ii)  When based on partial cost, normal use allowance and
depreciation—</p>
<p style="margin-left: 1in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(A)  Apply to the balance of costs during the special use
allowance period to the extent negotiated in the special use
allowance agreement; and</p>
<p style="margin-left: 1in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(B)  Do not apply after the special use allowance period,
except for normal use allowance applied to the balance.</p>
<p style="margin-left: 0.5in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(3)  During the special use allowance period, the research
facility—</p>
<p style="margin-left: 0.75in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(i)  Shall be available for Government research use on a
priority basis over nongovernment use; and</p>
<p style="margin-left: 0.75in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(ii)  Cannot be put to any significant use other than that
which justified the special use allowance, unless the head of the
contracting activity, who approved the special use allowance,
consents.</p>
<p style="margin-left: 0.5in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(4)  The Government will pay only an allocable share of the
special use allowance when the institution makes any substantial use
of the research facility for parties other than the Government during
the period when the special use allowance is in effect.</p>
<p style="margin-left: 0.5in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(5)  In no event shall the institution be paid more than the
acquisition costs.</p>
<h3 class="western"><a name="_Toc37754408"></a><a name="_Toc37677498"></a><a name="_Toc37345928"></a>
235.016  Broad agency announcement.</h3>
<p style="margin-bottom: 0in; line-height: 100%"><b><br/>
</b><span lang="en">(a)
 </span><span lang="en"><i>General</i></span><span lang="en">.  A
broad agency announcement with peer or scientific review may be used
for the award of science and technology proposals</span>.  Science
and technology proposals include proposals for the following:</p>
<p style="margin-left: 0.75in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<span lang="en"><br/>
</span>(i)  Basic research (budget activity
6.1).</p>
<p style="margin-left: 0.75in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(ii)  Applied research (budget activity 6.2).</p>
<p style="margin-left: 0.75in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(iii)  Advanced technology development (budget activity 6.3).</p>
<p style="margin-left: 0.75in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(iv)  Advanced component development and prototypes (budget
activity 6.4).</p>
<h3 class="western"><a name="_Toc37754409"></a><a name="_Toc37677499"></a><a name="_Toc37345929"></a>
<br/>
235.017  Federally Funded Research and Development Centers.</h3>
<p style="margin-bottom: 0in; line-height: 100%"><b><br/>
</b>(a) 
<i>Policy.</i></p>
<p style="margin-left: 0.5in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(2)  No DoD fiscal year 1992 or later funds may be obligated or
expended to finance activities of a DoD Federally Funded Research and
Development Center (FFRDC) if a member of its board of directors or
trustees simultaneously serves on the board of directors or trustees
of a profit-making company under contract to DoD, unless the FFRDC
has a DoD-approved conflict of interest policy for its members
(Section 8107 of Pub. L. 102-172 and similar sections in subsequent
Defense appropriations acts).</p>
<h4 class="western"><a name="_Toc37754410"></a><a name="_Toc37677500"></a>
<br/>
235.017-1  Sponsoring agreements.</h4>
<p style="margin-bottom: 0in; line-height: 100%"><b><br/>
</b>(c)(4) 
DoD-sponsored FFRDCs that function primarily as research laboratories
(C3I Laboratory operated by the Institute for Defense Analysis,
Lincoln Laboratory operated by Massachusetts Institute of Technology,
and Software Engineering Institute operated by Carnegie Mellon) may
respond to solicitations and announcements for programs which promote
research, development, demonstration, or transfer of technology
(Section 217, Pub. L. 103-337).</p>
<h3 class="western"><a name="_Toc37754411"></a><a name="_Toc37677501"></a><a name="_Toc37345930"></a>
<br/>
235.070  Indemnification against unusually hazardous risks.</h3>
<h4 class="western"><a name="_Toc37754412"></a><a name="_Toc37677502"></a>
<span style="font-weight: normal"><br/>
</span>235.070-1 
Indemnification under research and development contracts.</h4>
<p style="margin-bottom: 0in; line-height: 100%"><b><br/>
</b>(a) 
Under 10 U.S.C. 2354, and if authorized by the Secretary concerned,
contracts for research and/or development may provide for
indemnification of the contractor or subcontractors for—</p>
<p style="margin-left: 0.5in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(1)  Claims by third persons (including employees) for death,
bodily injury, or loss of or damage to property; and</p>
<p style="margin-left: 0.5in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(2)  Loss of or damage to the contractor's property to the
extent that the liability, loss, or damage—</p>
<p style="margin-left: 0.75in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(i)  Results from a risk that the contract defines as
 unusually hazardous; </p>
<p style="margin-left: 0.75in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(ii)  Arises from the direct performance of the contract; and</p>
<p style="margin-left: 0.75in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(iii)  Is not compensated by insurance or other means.</p>
<p style="margin-bottom: 0in; line-height: 100%"><br/>
(b)  Clearly
define the specific unusually hazardous risks to be indemnified. 
Submit this definition for approval with the request for
authorization to grant indemnification.  Include the approved
definition in the contract.</p>
<h4 class="western"><a name="_Toc37754413"></a><a name="_Toc37677503"></a>
<br/>
235.070-2  Indemnification under contracts involving both
research and development and other work.</h4>
<p class="western" style="margin-bottom: 0.11in; line-height: 108%">These
contracts may provide for indemnification under the authority of both
10 U.S.C. 2354 and Pub. L. 85-804.  Pub. L. 85-804 will apply only to
work to which 10 U.S.C. 2354 does not apply.  Actions under Pub. L.
85-804 must also comply with FAR 50.104-3. 
</p>
<h4 class="western"><a name="_Toc37754414"></a><a name="_Toc37677504"></a>
<br/>
235.070-3  Contract clauses.</h4>
<p class="western" style="margin-bottom: 0.11in; line-height: 108%">When
the contractor is to be indemnified in accordance with <a href="https://www.acq.osd.mil/dpap/dars/dfars/html/current/235_0.htm#235.070-1">235.070-1</a>,
use either—</p>
<p style="margin-bottom: 0in; line-height: 100%"><br/>
(a)  The
clause at <a href="https://www.acq.osd.mil/dpap/dars/dfars/html/current/252235.htm#252.235-7000">252.235-7000</a>,
Indemnification Under 10 U.S.C. 2354--Fixed Price; or</p>
<p style="margin-bottom: 0in; line-height: 100%"><br/>
(b)  The
clause at <a href="https://www.acq.osd.mil/dpap/dars/dfars/html/current/252235.htm#252.235-7001">252.235-7001</a>,
Indemnification Under 10 U.S.C. 2354--Cost-Reimbursement, as
appropriate.</p>
<h3 class="western"><a name="_Toc37754415"></a><a name="_Toc37677505"></a><a name="_Toc37345931"></a>
<br/>
235.071  Export-controlled items.</h3>
<p style="margin-bottom: 0in; line-height: 0.17in; orphans: 0; widows: 0">
<font face="Courier New, serif"><font face="Century Schoolbook, serif">For
requirements regarding access to export-controlled items, see
<a href="https://www.acq.osd.mil/dpap/dars/dfars/html/current/225_79.htm#225.7901">225.7901</a>.
</font></font>
</p>
<h3 class="western"><a name="_Toc37754416"></a><a name="_Toc37677506"></a><a name="_Toc37345932"></a>
<span style="font-weight: normal"><br/>
</span>235.072  Additional
contract clauses.</h3>
<p style="margin-bottom: 0in; line-height: 100%"><b><br/>
</b>(a) 
Use a clause substantially the same as the clause at <a href="https://www.acq.osd.mil/dpap/dars/dfars/html/current/252235.htm#252.235-7002">252.235-7002</a>,
Animal Welfare, in solicitations and contracts involving research,
development, test, and evaluation or training that use live
vertebrate animals.</p>
<p style="margin-bottom: 0in; line-height: 100%"><br/>
<span style="letter-spacing: -0.3pt">(b)
 Use the basic or the alternate of the clause at </span><a href="https://www.acq.osd.mil/dpap/dars/dfars/html/current/252235.htm#252.235-7003"><font color="#0000ff"><span style="letter-spacing: -0.3pt"><u>252.235-7003</u></span></font></a><span style="letter-spacing: -0.3pt">,
Frequency Authorization, in solicitations and contracts for
developing, producing, constructing, testing, or operating a device
requiring a frequency authorization.</span></p>
<p style="margin-left: 0.5in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<span style="letter-spacing: -0.3pt"><b><br/>
</b></span><span style="letter-spacing: -0.3pt">(1)
 Use the basic clause if agency procedures do not authorize the use
of DD Form 1494, Application for Equipment Frequency Allocation, to
obtain radio frequency authorization.</span></p>
<p style="margin-left: 0.5in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<span style="letter-spacing: -0.3pt"><b><br/>
</b></span><span style="letter-spacing: -0.3pt">(2)
 Use the alternate I clause if agency procedures authorize the use of
DD Form 1494, Application for Equipment Frequency Allocation, to
obtain frequency authorization.</span></p>
<p style="margin-bottom: 0in; line-height: 100%"><span style="letter-spacing: -0.3pt"><b><br/>
</b></span>(c)
 Use the clause at <a href="https://www.acq.osd.mil/dpap/dars/dfars/html/current/252235.htm#252.235-7010">252.235-7010</a>,
Acknowledgment of Support and Disclaimer, in solicitations and
contracts for research and development.</p>
<p style="margin-bottom: 0in; line-height: 100%"><br/>
(d)  Use the
clause at <a href="https://www.acq.osd.mil/dpap/dars/dfars/html/current/252235.htm#252.235-7011">252.235-7011</a>,
Final Scientific or Technical Report, in solicitations and contracts
for research and development.</p>
<p style="margin-bottom: 0in; line-height: 100%"><br/>
(e)  Use the
clause at <a href="https://www.acq.osd.mil/dpap/dars/dfars/html/current/252235.htm#252.235-7004">252.235-7004</a>,
Protection of Human Subjects, in solicitations and contracts that
include or may include research involving human subjects in
accordance with 32 CFR Part 219, DoD Directive 3216.02, and 10 U.S.C.
980, including research that meets exemption criteria under 32 CFR
219.101(b).  The clause—</p>
<p style="margin-left: 0.5in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(1)  Applies to solicitations and contracts awarded by any DoD
component, regardless of mission or funding Program Element Code; and</p>
<p style="margin-left: 0.5in; text-indent: -0.25in; margin-bottom: 0in; line-height: 100%">
<br/>
(2)  Does not apply to use of cadaver materials alone, which
are not directly regulated by 32 CFR Part 219 or DoD Directive
3216.02, and which are governed by other DoD policies and applicable
State and local laws.</p>
<p class="western" style="margin-bottom: 0.11in; line-height: 108%"><br/>
<br/>
<br/>

</p>
<h2 class="western" style="page-break-before: always"><a name="BM235_70"></a><a name="_Toc37754417"></a><a name="_Toc37677507"></a><a name="_Toc37345933"></a>
<span style="text-transform: uppercase">SUBPART 235.70</span></h2>
<p class="western" align="center" style="margin-bottom: 0.11in; line-height: 108%">
<i>(Removed November 22, 2004)</i></p>
<p class="western" style="margin-bottom: 0.11in; line-height: 108%"><br/>
<br/>
<br/>

</p>
<p class="western" style="margin-bottom: 0.11in; line-height: 108%"><br/>
<br/>

</p>

        <div class="regnavigation">
            
            <p>
                <a href="DFARS234.html#TopOfPage"><img src="/sites/all/themes/acquisition-responsive/images/prev-part.jpg" alt="Previous Page" border="0"></a>
                <a href="#TopOfPage"><img src="/sites/all/themes/acquisition-responsive/images/regtop.jpg" alt="Top Of Page" border="0"></a>
            </p>
            <p><a href="/dfars#TopOfPage" target="_top"><img src="/sites/all/themes/acquisition-responsive/images/toc.jpg" alt="Table Of Contents" border="0"></a></p>
            <p><a href="DFARS236.html#TopOfPage"><img src="/sites/all/themes/acquisition-responsive/images/next-part.jpg" alt="Next Page" border="0"></a></p>
        </div></body>
</html>